MAPT rs242562 and GSK3B rs334558 are associated with Parkinson’s Disease in central China

Lan Yu,Jinsha Huang,Desheng Zhai,Ling Liu,Kexin Guo,Xi Long,Jing Xiong,Zhentao Zhang,Youpei Wang,Ying Zhao,Ping Wu,Dingan Wang,Zhicheng Lin,Jing Wu,Nian Xiong,Tao Wang

DOI: https://doi.org/10.1186/1471-2202-15-54

2014-01-01

BMC Neuroscience

Abstract:Background Microtubule-associated protein tau (MAPT) is a neuronal protein involved in the pathogenesis of several neurodegenerative diseases including Parkinson’s Disease (PD). Glycogen synthase kinase 3 beta (GSK3B) catalyzes phosphorylation in multiple sites of tau protein. However, whether or not there is any association between the GSK3B gene alteration, MAPT haplotype and PD remains unexplored in Chinese population, especially in central Chinese population. Results Here, we aimed at studying the effect of MAPT rs242562 and GSK3B rs334558 on the risk of PD by performing a case-control association study in central China. Our data showed that all PD patients and controls were of MAPT H1/H1 diplotype in our study, thus confirming that the distribution of the MAPT H1 haplotype is common in China. GG genotype of MAPT rs242562 serves protection effect on PD risk in central Chinese population, while genotype of GSK3B rs334558 showed no difference between PD patients and controls. Conclusions We conclude that the MAPT rs242562 is associated with PD in central China in the background of MAPT H1/H1 diplotype. The GG genotype of rs242562 displays protection against PD in subgroup with GSK3B rs334558 T carrier.